SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-006484
Filing Date
2018-05-09
Accepted
2018-05-09 17:01:25
Documents
68
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 552554
2 ex10-1.htm EX-10.1 9461
3 ex31-1.htm EX-31.1 10655
4 ex31-2.htm EX-31.2 11071
5 ex32-1.htm EX-32.1 5076
6 image_001.jpg GRAPHIC 183882
7 image_002.jpg GRAPHIC 190184
8 image_003.jpg GRAPHIC 176691
9 image_004.jpg GRAPHIC 190004
10 image_005.jpg GRAPHIC 196368
11 image_006.jpg GRAPHIC 203232
12 image_007.jpg GRAPHIC 184027
13 image_008.jpg GRAPHIC 67170
14 image_009.jpg GRAPHIC 24688
15 image_010.jpg GRAPHIC 47369
  Complete submission text file 0001493152-18-006484.txt   5086239

Data Files

Seq Description Document Type Size
16 XBRL INSTANCE FILE mtnb-20180331.xml EX-101.INS 436317
17 XBRL SCHEMA FILE mtnb-20180331.xsd EX-101.SCH 41647
18 XBRL CALCULATION FILE mtnb-20180331_cal.xml EX-101.CAL 47266
19 XBRL DEFINITION FILE mtnb-20180331_def.xml EX-101.DEF 164190
20 XBRL LABEL FILE mtnb-20180331_lab.xml EX-101.LAB 281473
21 XBRL PRESENTATION FILE mtnb-20180331_pre.xml EX-101.PRE 220175
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38022 | Film No.: 18819232
SIC: 2834 Pharmaceutical Preparations